Osphena

Chemical Nameospemifene
Dosage FormTablet (oral; 60 mg)
Drug ClassModulators
SystemFemale reproductive
CompanyDuchesnay
Approval Year2013

Indication

  • For the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause.
  • For the treatment of moderate to severe vaginal dryness, a symptom of vulvar and vaginal atrophy, due to menopause.
Last updated on 6/22/2022

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Osphena (ospemifene) Prescribing Information.2019Duchesnay USA, Inc., Bryn Mawr, PA
Document TitleYearSource
Assessment report: Senshio. 2015EMA